查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1553439

單光子發射斷層掃描市場規模、佔有率、趨勢分析報告：按產品、應用、最終用途、地區和細分市場預測，2024-2030 年

Single-photon Emission Computed Tomography Market Size, Share & Trends Analysis Report By Product (Stand-alone SPECT Systems, Hybrid SPECT Systems), By Application (Cardiology, Oncology), By End Use, By Region, And Segment Forecasts, 2024 - 2030
出版日期: | 出版商: Grand View Research | 英文 180 Pages | 商品交期: 2-10個工作天內

價格

單光子發射斷層掃描市場成長與趨勢：

Grand View Research, Inc.最新報告顯示，預計2030年全球單光子發射斷層掃描市場規模將達45.4億美元，2024年至2030年複合年成長率為2.78%。

市場由幾個關鍵因素驅動。主要市場促進因素之一是癌症盛行率的增加。癌症、心血管疾病和神經系統疾病等慢性疾病盛行率的增加是單光子發射電腦斷層掃描(SPECT) 市場的關鍵促進因素。

隨著人口老化，這些疾病的盛行率增加，增加了對 SPECT 影像等準確診斷工具的需求。這一趨勢需要引入先進的影像技術，這些技術可以提供有關疾病進展和治療效果的詳細見解，從而推動該地區的 SPECT 市場。

政府透過資助醫療設施和改善先進成像技術的舉措來提供支持，進一步推動了市場成長。此外，SPECT 與 CT (SPECT/CT) 等其他影像方式的整合提高了診斷準確性並擴展了其在各個醫學領域的應用。製造商和醫療保健提供者正在積極合作，以推進 SPECT 技術並擴大其臨床應用。

Cardinal Health、GE Healthcare 和Siemens Healthineers 等市場主要企業正在投資研發以創新和最佳化 SPECT 系統。這些公司還與醫院和研究機構建立合作夥伴關係，以促進臨床試驗和 SPECT 成像所需的新型放射性藥物的推出。製造商和醫療機構之間的合作使臨床醫生更容易獲得最新技術並改善患者的治療效果。

新產品的推出和最尖端科技的整合是 SPECT 市場的主要趨勢。最近的發展包括開發高解析度成像系統和新型放射性藥物，以提高 SPECT 掃描的靈敏度和特異性。例如，引進最先進的掃描儀預計將改變 QEII 健康科學中心的核子醫學服務，為臨床醫生提供更好的診斷和治療計劃的增強工具。這符合該中心透過實施創新技術提供優質醫療保健的承諾。安裝此類掃描儀是對醫療基礎設施的一項重要投資，旨在改善患者的治療結果。

此外，將 SPECT/CT 等混合成像系統引入醫院環境，將提供準確診斷和治療計劃所需的全面解剖和功能成像，從而徹底改變該領域。例如，2024年5月，Mercy Sullivan醫院安裝了高科技SPECT/CT影像系統，以增強其診斷能力。此新系統整合了先進的SPECT和CT技術，旨在為各種醫療狀況提供詳細且準確的影像診斷。

該裝置對醫院來說是一次重大升級，提高了其更有效地診斷和監測疾病的能力。新的 SPECT/CT 系統旨在透過提供更高解析度的影像和更準確的診斷資訊來支援更好的患者照護。這些創新不僅提高了診斷能力，還促進了醫療保健專業人員之間的跨學科合作，從而製定更有效的患者管理策略。

該市場的主要參與者包括 GE Healthcare、Siemens Healthcare、Koninklijke Philips NV、Spectrum Dynamics Medical、Digirad Corporation、MILabs BV、Mediso Medical Imaging Systems 和 MiE GmbH。主要企業正在採取產品發布等策略措施來服務全球客戶。 2022 年 10 月， 頻譜 Dynamics 推出 VERITON-CT-400 系列數位 SPECT/CT 掃描儀，宣布數位核醫學影像領域取得進展。這些新型掃描儀採用固體檢測器技術並具有寬口徑配置，使它們能夠以更高的精度和能力對高能量同位素進行成像。

單光子發射斷層掃描市場報告亮點：

  • 從產品來看，混合SPECT系統佔最大的銷售佔有率，2023年將達到67.12%。這些混合系統將 SPECT 的功能性影像功能與 CT 或 MRI 提供的解剖細節整合在一起，提供全面的視圖，提高診斷準確性和治療計劃。混合SPECT 系統用於各種醫療應用，包括腫瘤學、循環系統和神經學，可提供對身體生理和解剖學方面的詳細了解。
  • 從應用來看，腫瘤學佔據市場主導地位，2023年佔最大佔有率，達49.58%。全球癌症發生率上升正在推動核醫學影像市場的成長，尤其是 PET 和 SPECT 技術。這些先進的方法因其無與倫比的可視化癌症分子特徵的能力而被廣泛採用，使人們對這種疾病有了更深入的了解。
  • 以最終用途計算，到 2023 年，醫院產業將佔據最大的市場佔有率，達到 46.9%。這是由於醫院先進的成像技術能夠及早發現癌症和心血管疾病，從而實現快速介入和治療。此外，醫院和其他公司之間為滿足臨床需求而建立的聯盟和合作關係也有助於市場成長。
  • 由於成熟的醫療保健產業、對創新的承諾、先進的基礎設施、對研發的重視、癌症和慢性病的高盛行率以及創新技術的快速採用等因素，北美在全球市場佔據主導地位。
  • 預計 2024 年至 2030 年期間，亞太地區將以 3.51% 的複合年成長率成長最快。

目錄

第1章調查方法和範圍

第 2 章執行摘要

第 3 章 單光子發射斷層掃描 (SPECT) 市場變數、趨勢與範圍

  • 市場體系展望
    • 母市場展望
    • 相關/附隨市場展望
  • 市場動態
    • 市場推動要素分析
    • 市場限制因素分析
  • 單光子發射斷層掃描 (SPECT) 市場分析工具
    • 產業分析-波特五力分析
    • PESTEL分析

第 4 章 單光子發射斷層掃描 (SPECT) 市場：按產品分類的估計和趨勢分析

  • 細分儀表板
  • 全球單光子發射斷層掃描市場：產品變化分析
  • 2018-2030年全球單光子發射斷層掃描市場規模及趨勢分析
  • 獨立 SPECT 系統
  • 混合SPECT系統

第5章單光子發射斷層掃描 (SPECT) 市場：按應用估算和趨勢分析

  • 細分儀表板
  • 全球單光子發射斷層掃描市場：應用變化分析
  • 2018-2030年全球單光子發射斷層掃描市場規模及趨勢分析
  • 2018-2030年市場規模、預測及趨勢分析
  • 心臟病學
    • 2018-2030年市場估計與預測
  • 腫瘤學
    • 2018-2030年市場估計與預測
  • 神經病學
    • 2018-2030年市場估計與預測
  • 其他應用
    • 2018-2030年市場估計與預測

第 6 章 單光子發射斷層掃描 (SPECT) 市場：最終用途的估計和趨勢分析

  • 細分儀表板
  • 全球單光子發射斷層掃描市場：最終用途變化分析
  • 2018-2030年全球單光子發射斷層掃描市場規模及趨勢分析
  • 醫院
  • 影像診斷中心
  • 其他

第 7 章 單光子發射斷層掃描 (SPECT) 市場：按產品、應用和最終用途進行的區域估計和趨勢分析

  • 2023 年及 2030 年區域市場佔有率分析
  • 區域市場儀表板
  • 全球區域市場概述
  • 2018-2030年市場規模、預測趨勢分析：
  • 北美洲
  • 歐洲
  • 亞太地區
  • 拉丁美洲
  • 中東/非洲

第8章 競爭格局

  • 主要市場參與企業的最新趨勢和影響分析
  • 公司/競爭對手分類
  • 2023年主要企業市場佔有率分析
  • 公司定位分析
  • 公司分類（新興企業、創新企業、領導者）
  • 公司簡介
    • GE Healthcare
    • Siemens Healthineers
    • Koninklijke Philips NV
    • Spectrum Dynamics Medical
    • Digirad Corporation
    • MILabs BV
    • Mediso Medical Imaging Systems
    • MiE GmbH
Product Code: GVR-4-68040-411-5

Single-photon Emission Computed Tomography Market Growth & Trends:

The global single-photon emission computed tomography market size is expected to reach USD 4.54 billion by 2030, registering a CAGR of 2.78% from 2024 to 2030, according to a new report by Grand View Research, Inc. The market is driven by several key factors. One of the primary market drivers is the increasing prevalence of cancer. The increasing prevalence of chronic disorders such as cancer, cardiovascular diseases, and neurological conditions is a significant driver of the single-photon emission computed tomography (SPECT) market.

As the population ages, the incidence of these diseases rises, creating a greater demand for accurate diagnostic tools such as SPECT imaging. This trend necessitates the adoption of advanced imaging technologies that can provide detailed insights into disease progression and treatment efficacy, thereby boosting the SPECT market in the region.

Government support through funding for healthcare facilities and initiatives to improve access to advanced imaging technologies is further propelling market growth. In addition, the integration of SPECT with other imaging modalities, such as CT (SPECT/CT), enhances diagnostic accuracy and expands its applications in various medical fields.Manufacturers and healthcare providers are actively collaborating to advance SPECT technology and expand its use in clinical practice.

Major players in the market, such as Cardinal Health, GE Healthcare, and Siemens Healthineers, are investing in research and development to innovate and optimize SPECT systems. These companies are also forming partnerships with hospitals and research institutions to facilitate clinical trials and the introduction of new radiopharmaceuticals, which are essential for SPECT imaging. The collaboration between manufacturers and healthcare facilities ensures that the latest technologies are readily available to clinicians, thereby improving patient outcomes.

The launch of new products and the integration of cutting-edge technologies are key trends in the SPECT market. Recent advancements include the development of high-resolution imaging systems and novel radiopharmaceuticals that enhance the sensitivity and specificity of SPECT scans. For instance, the introduction of a cutting-edge scanner is expected to transform nuclear medicine services at QEII Health Sciences Centre by providing clinicians with enhanced tools for better diagnosis and treatment planning. This aligns with the center's commitment to delivering high-quality healthcare through the adoption of innovative technologies. Such scanner's installation represents a significant investment in healthcare infrastructure, aimed at improving patient outcomes.

Further, the introduction of hybrid imaging systems such as SPECT/CT in hospital settings has revolutionized the field by providing comprehensive anatomical and functional imaging, which is crucial for accurate diagnosis and treatment planning. For instance, in May 2024, Mercy Sullivan Hospital installed a high-tech SPECT/CT imaging system, enhancing its diagnostic capabilities. The new system, which integrates advanced SPECT and CT technologies, was designed to provide detailed and accurate imaging for a variety of medical conditions.

The installation marked a significant upgrade for the hospital, improving its ability to diagnose and monitor diseases more effectively. The new SPECT/CT system aims to support better patient care by offering higher resolution images and more precise diagnostic information.These innovations not only improve diagnostic capabilities but also foster greater interdisciplinary collaboration among healthcare professionals, leading to more effective patient management strategies.

Some of the key players in the market are GE Healthcare, Siemens Healthineers, Koninklijke Philips N.V., Spectrum Dynamics Medical, Digirad Corporation, MILabs B.V., Mediso Medical Imaging Systems, MiE GmbH. Key player are involved in undertaking strategic initiatives such as product launch to cater global clientele. In October 2022, Spectrum Dynamics announced its advancement in digital nuclear medicine imaging with the launch of the VERITON-CT-400 Series Digital SPECT/CT scanners. These new scanners utilize solid-state detector technology and feature a wide-bore configuration, enabling them to image high-energy isotopes with enhanced precision and capability.

Single-photon Emission Computed Tomography Market Report Highlights:

  • Based on product, hybrid SPECT systems accounted for largest revenue share of 67.12% in 2023. These hybrid systems integrate SPECT's functional imaging capabilities with the anatomical detail provided by CT or MRI, offering a comprehensive view that enhances diagnostic accuracy and treatment planning. Hybrid SPECT systems are used in various medical applications, including oncology, cardiology, and neurology, to provide detailed insights into the physiological and anatomical aspects of the body
  • Based on application, oncology dominated the market and accounted for the largest share of 49.58% in 2023. The rising global incidence of cancer is driving the growth of the nuclear imaging market, particularly in PET and SPECT technologies. These advanced modalities have gained widespread adoption due to their unparalleled ability to visualize the molecular characteristics of cancer, providing a deeper understanding of the disease
  • Based on end use, hospitals segment is dominated the end use segments with the largest market share of 46.9% in 2023. This is attributable to advanced imaging technologies in hospitals that enable the early detection of cancer, CVD's, allowing for prompt intervention and treatment. In addition, partnerships & collaborations between hospitals and other companies to meet clinical needs contribute to market growth
  • North America dominated the global market due to the attributed to the well-established healthcare sector, commitment to innovation, advanced infrastructure, a strong emphasis on R&D, the high prevalence of cancer and chronic diseases, and rapid adoption of innovative technologies
  • Asia Pacific region is expected to witness fastest growth with a CAGR of 3.51% over the forecast period from 2024 to 2030, due to presence of manufacturers with innovative devices manufacturing capabilities coupled with accelerated diagnostic research capabilities

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation & Scope
  • 1.2. Segment Definitions
    • 1.2.1. Product
    • 1.2.2. Application
    • 1.2.3. End Use
    • 1.2.4. Regional scope
    • 1.2.5. Estimates and forecasts timeline
  • 1.3. Research Methodology
  • 1.4. Information Procurement
    • 1.4.1. Purchased database
    • 1.4.2. GVR's internal database
    • 1.4.3. Secondary sources
    • 1.4.4. Primary research
    • 1.4.5. Details of primary research
      • 1.4.5.1. Data for primary interviews in North America
      • 1.4.5.2. Data for primary interviews in Europe
      • 1.4.5.3. Data for primary interviews in Asia Pacific
      • 1.4.5.4. Data for primary interviews in Latin America
      • 1.4.5.5. Data for Primary interviews in MEA
  • 1.5. Information or Data Analysis
    • 1.5.1. Data analysis models
  • 1.6. Market Formulation & Validation
  • 1.7. Model Details
    • 1.7.1. Commodity flow analysis (Model 1)
    • 1.7.2. Approach 1: Commodity flow approach
    • 1.7.3. Volume price analysis (Model 2)
    • 1.7.4. Approach 2: Volume price analysis
  • 1.8. List of Secondary Sources
  • 1.9. List of Primary Sources
  • 1.10. Objectives

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Outlook
    • 2.2.1. Product outlook
    • 2.2.2. Application outlook
    • 2.2.3. End use outlook
    • 2.2.4. Regional outlook
  • 2.3. Competitive Insights

Chapter 3. Single-Photon Emission Computed Tomography (SPECT) Market Variables, Trends & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent market outlook
    • 3.1.2. Related/ancillary market outlook
  • 3.2. Market Dynamics
    • 3.2.1. Market driver analysis
      • 3.2.1.1. Rising prevalence of cancer
      • 3.2.1.2. Technological advancements
      • 3.2.1.3. Increasing awareness of diagnostic needs
    • 3.2.2. Market restraint analysis
      • 3.2.2.1. lack of skilled professionals
  • 3.3. Single-Photon Emission Computed Tomography (SPECT) Market Analysis Tools
    • 3.3.1. Industry Analysis - Porter's
      • 3.3.1.1. Supplier power
      • 3.3.1.2. Buyer power
      • 3.3.1.3. Substitution threat
      • 3.3.1.4. Threat of new entrant
      • 3.3.1.5. Competitive rivalry
    • 3.3.2. PESTEL Analysis
      • 3.3.2.1. Political landscape
      • 3.3.2.2. Technological landscape
      • 3.3.2.3. Economic landscape

Chapter 4. Single-Photon Emission Computed Tomography (SPECT) Market: Product Estimates & Trend Analysis

  • 4.1. Segment Dashboard
  • 4.2. Global Single-Photon Emission Computed Tomography (SPECT) Product Market Movement Analysis
  • 4.3. Global Single-Photon Emission Computed Tomography (SPECT) Market Size & Trend Analysis, by Product, 2018 to 2030 (USD Million)
  • 4.4. Stand-alone SPECT Systems
    • 4.4.1. Stand-alone SPECT systems market estimates and forecasts 2018 to 2030 (USD Million)
  • 4.5. Hybrid SPECT Systems
    • 4.5.1. Hybrid SPECT systems market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 5. Single-Photon Emission Computed Tomography (SPECT) Market: Application Estimates & Trend Analysis

  • 5.1. Segment Dashboard
  • 5.2. Global Single-Photon Emission Computed Tomography (SPECT) Application Market Movement Analysis
  • 5.3. Global Single-Photon Emission Computed Tomography (SPECT) Market Size & Trend Analysis, by Application, 2018 to 2030 (USD Million)
  • 5.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
  • 5.5. Cardiology
    • 5.5.1. Cardiology market estimates and forecasts 2018 to 2030 (USD Million)
  • 5.6. Oncology
    • 5.6.1. Oncology market estimates and forecasts 2018 to 2030 (USD Million)
  • 5.7. Neurology
    • 5.7.1. Neurology market estimates and forecasts 2018 to 2030 (USD Million)
  • 5.8. Other Application
    • 5.8.1. Other application market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 6. Single-Photon Emission Computed Tomography (SPECT) Market: End Use Estimates & Trend Analysis

  • 6.1. Segment Dashboard
  • 6.2. Global Single-Photon Emission Computed Tomography (SPECT) End Use Market Movement Analysis
  • 6.3. Global Single-Photon Emission Computed Tomography (SPECT) Market Size & Trend Analysis, by End Use, 2018 to 2030 (USD Million)
  • 6.4. Hospitals
    • 6.4.1. Hospitals market estimates and forecasts 2018 to 2030 (USD Million)
  • 6.5. Diagnostic Imaging Centers
    • 6.5.1. Diagnostic imaging centers market estimates and forecasts 2018 to 2030 (USD Million)
  • 6.6. Others
    • 6.6.1. Others market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 7. Single-Photon Emission Computed Tomography (SPECT) Market: Regional Estimates & Trend Analysis By Product, Application, End Use

  • 7.1. Regional Market Share Analysis, 2023 & 2030
  • 7.2. Regional Market Dashboard
  • 7.3. Global Regional Market Snapshot
  • 7.4. Market Size, & Forecasts Trend Analysis, 2018 to 2030:
  • 7.5. North America
    • 7.5.1. U.S.
      • 7.5.1.1. Key country dynamics
      • 7.5.1.2. Competitive scenario
      • 7.5.1.3. Regulatory framework/ reimbursement structure
      • 7.5.1.4. U.S. market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.5.2. Canada
      • 7.5.2.1. Key country dynamics
      • 7.5.2.2. Competitive scenario
      • 7.5.2.3. Regulatory framework/ reimbursement structure
      • 7.5.2.4. Canada market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.5.3. Mexico
      • 7.5.3.1. Key country dynamics
      • 7.5.3.2. Competitive scenario
      • 7.5.3.3. Regulatory framework/ reimbursement structure
      • 7.5.3.4. Canada market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.6. Europe
    • 7.6.1. Regulatory framework/ reimbursement structure
    • 7.6.2. UK
      • 7.6.2.1. Key country dynamics
      • 7.6.2.2. Competitive scenario
      • 7.6.2.3. Regulatory framework/ reimbursement structure
      • 7.6.2.4. UK market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.6.3. Germany
      • 7.6.3.1. Key country dynamics
      • 7.6.3.2. Competitive scenario
      • 7.6.3.3. Regulatory framework/ reimbursement structure
      • 7.6.3.4. Germany market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.6.4. France
      • 7.6.4.1. Key country dynamics
      • 7.6.4.2. Competitive scenario
      • 7.6.4.3. Regulatory framework/ reimbursement structure
      • 7.6.4.4. France market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.6.5. Italy
      • 7.6.5.1. Key country dynamics
      • 7.6.5.2. Competitive scenario
      • 7.6.5.3. Regulatory framework/ reimbursement structure
      • 7.6.5.4. Italy market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.6.6. Spain
      • 7.6.6.1. Key country dynamics
      • 7.6.6.2. Competitive scenario
      • 7.6.6.3. Regulatory framework/ reimbursement structure
      • 7.6.6.4. Spain market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.6.7. Norway
      • 7.6.7.1. Key country dynamics
      • 7.6.7.2. Competitive scenario
      • 7.6.7.3. Regulatory framework/ reimbursement structure
      • 7.6.7.4. Norway market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.6.8. Sweden
      • 7.6.8.1. Key country dynamics
      • 7.6.8.2. Competitive scenario
      • 7.6.8.3. Regulatory framework/ reimbursement structure
      • 7.6.8.4. Sweden market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.6.9. Denmark
      • 7.6.9.1. Key country dynamics
      • 7.6.9.2. Competitive scenario
      • 7.6.9.3. Regulatory framework/ reimbursement structure
      • 7.6.9.4. Denmark market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.7. Asia Pacific
    • 7.7.1. Regulatory framework/ reimbursement structure
    • 7.7.2. Japan
      • 7.7.2.1. Key country dynamics
      • 7.7.2.2. Competitive scenario
      • 7.7.2.3. Regulatory framework/ reimbursement structure
      • 7.7.2.4. Japan market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.7.3. China
      • 7.7.3.1. Key country dynamics
      • 7.7.3.2. Competitive scenario
      • 7.7.3.3. Regulatory framework/ reimbursement structure
      • 7.7.3.4. China market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.7.4. India
      • 7.7.4.1. Key country dynamics
      • 7.7.4.2. Competitive scenario
      • 7.7.4.3. Regulatory framework/ reimbursement structure
      • 7.7.4.4. India market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.7.5. Australia
      • 7.7.5.1. Key country dynamics
      • 7.7.5.2. Competitive scenario
      • 7.7.5.3. Regulatory framework/ reimbursement structure
      • 7.7.5.4. Australia market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.7.6. South Korea
      • 7.7.6.1. Key country dynamics
      • 7.7.6.2. Competitive scenario
      • 7.7.6.3. Regulatory framework/ reimbursement structure
      • 7.7.6.4. South Korea market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.7.7. Thailand
      • 7.7.7.1. Key country dynamics
      • 7.7.7.2. Competitive scenario
      • 7.7.7.3. Regulatory framework/ reimbursement structure
      • 7.7.7.4. Thailand market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.8. Latin America
    • 7.8.1. Regulatory framework/ reimbursement structure
    • 7.8.2. Brazil
      • 7.8.2.1. Key country dynamics
      • 7.8.2.2. Competitive scenario
      • 7.8.2.3. Regulatory framework/ reimbursement structure
      • 7.8.2.4. Brazil market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.8.3. Argentina
      • 7.8.3.1. Key country dynamics
      • 7.8.3.2. Competitive scenario
      • 7.8.3.3. Regulatory framework/ reimbursement structure
      • 7.8.3.4. Argentina market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.9. MEA
    • 7.9.1. Regulatory framework/ reimbursement structure
    • 7.9.2. South Africa
      • 7.9.2.1. Key country dynamics
      • 7.9.2.2. Competitive scenario
      • 7.9.2.3. Regulatory framework/ reimbursement structure
      • 7.9.2.4. South Africa market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.9.3. Saudi Arabia
      • 7.9.3.1. Key country dynamics
      • 7.9.3.2. Competitive scenario
      • 7.9.3.3. Regulatory framework/ reimbursement structure
      • 7.9.3.4. Saudi Arabia market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.9.4. UAE
      • 7.9.4.1. Key country dynamics
      • 7.9.4.2. Competitive scenario
      • 7.9.4.3. Regulatory framework/ reimbursement structure
      • 7.9.4.4. UAE market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.9.5. Kuwait
      • 7.9.5.1. Key country dynamics
      • 7.9.5.2. Competitive scenario
      • 7.9.5.3. Regulatory framework/ reimbursement structure
      • 7.9.5.4. Kuwait market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 8. Competitive Landscape

  • 8.1. Recent Developments & Impact Analysis, By Key Market Participants
  • 8.2. Company/Competition Categorization
  • 8.3. Key company market share analysis, 2023
  • 8.4. Company Position Analysis
  • 8.5. Company Categorization (Emerging Players, Innovators and Leaders
  • 8.6. Company Profiles
    • 8.6.1. GE Healthcare
      • 8.6.1.1. Company overview
      • 8.6.1.2. Financial performance
      • 8.6.1.3. Application benchmarking
      • 8.6.1.4. Strategic initiatives
    • 8.6.2. Siemens Healthineers
      • 8.6.2.1. Company overview
      • 8.6.2.2. Financial performance
      • 8.6.2.3. Application benchmarking
      • 8.6.2.4. Strategic initiatives
    • 8.6.3. Koninklijke Philips N.V.
      • 8.6.3.1. Company overview
      • 8.6.3.2. Financial performance
      • 8.6.3.3. Application benchmarking
      • 8.6.3.4. Strategic initiatives
    • 8.6.4. Spectrum Dynamics Medical
      • 8.6.4.1. Company overview
      • 8.6.4.2. Financial performance
      • 8.6.4.3. Application benchmarking
      • 8.6.4.4. Strategic initiatives
    • 8.6.5. Digirad Corporation
      • 8.6.5.1. Company overview
      • 8.6.5.2. Financial performance
      • 8.6.5.3. Application benchmarking
      • 8.6.5.4. Strategic initiatives
    • 8.6.6. MILabs B.V.
      • 8.6.6.1. Company overview
      • 8.6.6.2. Financial performance
      • 8.6.6.3. Application benchmarking
      • 8.6.6.4. Strategic initiatives
    • 8.6.7. Mediso Medical Imaging Systems
      • 8.6.7.1. Company overview
      • 8.6.7.2. Financial performance
      • 8.6.7.3. Application benchmarking
      • 8.6.7.4. Strategic initiatives
    • 8.6.8. MiE GmbH
      • 8.6.8.1. Company overview
      • 8.6.8.2. Financial performance
      • 8.6.8.3. Application benchmarking
      • 8.6.8.4. Strategic initiatives

List of Tables

  • Table 1 List of secondary sources
  • Table 2 List of abbreviations
  • Table 3 Global single-photon emission computed tomography (SPECT) market by Product, 2018 - 2030 (USD Million)
  • Table 4 Global single-photon emission computed tomography (SPECT) market by Application, 2018 - 2030 (USD Million)
  • Table 5 Global single-photon emission computed tomography (SPECT) market by End Use, 2018 - 2030 (USD Million)
  • Table 6 North America single-photon emission computed tomography (SPECT) market by Product, 2018 - 2030 (USD Million)
  • Table 7 North America single-photon emission computed tomography (SPECT) market by Application, 2018 - 2030 (USD Million)
  • Table 8 North America single-photon emission computed tomography (SPECT) market by End Use, 2018 - 2030 (USD Million)
  • Table 9 North America single-photon emission computed tomography (SPECT) market by Country, 2018 - 2030 (USD Million)
  • Table 10 U.S. single-photon emission computed tomography (SPECT) market by Product, 2018 - 2030 (USD Million)
  • Table 11 U.S. single-photon emission computed tomography (SPECT) market by Application, 2018 - 2030 (USD Million)
  • Table 12 U.S. single-photon emission computed tomography (SPECT) market by End Use, 2018 - 2030 (USD Million)
  • Table 13 Canada single-photon emission computed tomography (SPECT) market by Product, 2018 - 2030 (USD Million)
  • Table 14 Canada single-photon emission computed tomography (SPECT) market by Application, 2018 - 2030 (USD Million)
  • Table 15 Canada single-photon emission computed tomography (SPECT) market by End Use, 2018 - 2030 (USD Million)
  • Table 16 Mexico single-photon emission computed tomography (SPECT) market by Product, 2018 - 2030 (USD Million)
  • Table 17 Mexico single-photon emission computed tomography (SPECT) market by Application, 2018 - 2030 (USD Million)
  • Table 18 Mexico single-photon emission computed tomography (SPECT) market by End Use, 2018 - 2030 (USD Million)
  • Table 19 Europe single-photon emission computed tomography (SPECT) market by Product, 2018 - 2030 (USD Million)
  • Table 20 Europe single-photon emission computed tomography (SPECT) market by Application, 2018 - 2030 (USD Million)
  • Table 21 Europe single-photon emission computed tomography (SPECT) market by End Use, 2018 - 2030 (USD Million)
  • Table 22 Europe single-photon emission computed tomography (SPECT) market by Country, 2018 - 2030 (USD Million)
  • Table 23 UK single-photon emission computed tomography (SPECT) market by Product, 2018 - 2030 (USD Million)
  • Table 24 UK single-photon emission computed tomography (SPECT) market by Application, 2018 - 2030 (USD Million)
  • Table 25 UK single-photon emission computed tomography (SPECT) market by End Use, 2018 - 2030 (USD Million)
  • Table 26 Germany single-photon emission computed tomography (SPECT) market by Product, 2018 - 2030 (USD Million)
  • Table 27 Germany single-photon emission computed tomography (SPECT) market by Application, 2018 - 2030 (USD Million)
  • Table 28 Germany single-photon emission computed tomography (SPECT) market by End Use, 2018 - 2030 (USD Million)
  • Table 29 France single-photon emission computed tomography (SPECT) market by Product, 2018 - 2030 (USD Million)
  • Table 30 France single-photon emission computed tomography (SPECT) market by Application, 2018 - 2030 (USD Million)
  • Table 31 France single-photon emission computed tomography (SPECT) market by End Use, 2018 - 2030 (USD Million)
  • Table 32 Italy single-photon emission computed tomography (SPECT) market by Product, 2018 - 2030 (USD Million)
  • Table 33 Italy single-photon emission computed tomography (SPECT) market by Application, 2018 - 2030 (USD Million)
  • Table 34 Italy single-photon emission computed tomography (SPECT) market by End Use, 2018 - 2030 (USD Million)
  • Table 35 Spain single-photon emission computed tomography (SPECT) market by Product, 2018 - 2030 (USD Million)
  • Table 36 Spain single-photon emission computed tomography (SPECT) market by Application, 2018 - 2030 (USD Million)
  • Table 37 Spain single-photon emission computed tomography (SPECT) market by End Use, 2018 - 2030 (USD Million)
  • Table 38 Denmark single-photon emission computed tomography (SPECT) market by Product, 2018 - 2030 (USD Million)
  • Table 39 Denmark single-photon emission computed tomography (SPECT) market by Application, 2018 - 2030 (USD Million)
  • Table 40 Denmark single-photon emission computed tomography (SPECT) market by End Use, 2018 - 2030 (USD Million)
  • Table 41 Sweden single-photon emission computed tomography (SPECT) market by Product, 2018 - 2030 (USD Million)
  • Table 42 Sweden single-photon emission computed tomography (SPECT) market by Application, 2018 - 2030 (USD Million)
  • Table 43 Sweden single-photon emission computed tomography (SPECT) market by End Use, 2018 - 2030 (USD Million)
  • Table 44 Norway single-photon emission computed tomography (SPECT) market by Product, 2018 - 2030 (USD Million)
  • Table 45 Norway single-photon emission computed tomography (SPECT) market by Application, 2018 - 2030 (USD Million)
  • Table 46 Norway single-photon emission computed tomography (SPECT) market by End Use, 2018 - 2030 (USD Million)
  • Table 47 Asia Pacific single-photon emission computed tomography (SPECT) market by Product, 2018 - 2030 (USD Million)
  • Table 48 Asia Pacific single-photon emission computed tomography (SPECT) market by Application, 2018 - 2030 (USD Million)
  • Table 49 Asia Pacific single-photon emission computed tomography (SPECT) market by End Use, 2018 - 2030 (USD Million)
  • Table 50 Asia Pacific single-photon emission computed tomography (SPECT) market by Country, 2018 - 2030 (USD Million)
  • Table 51 China single-photon emission computed tomography (SPECT) market by Product, 2018 - 2030 (USD Million)
  • Table 52 China single-photon emission computed tomography (SPECT) market by Application, 2018 - 2030 (USD Million)
  • Table 53 China single-photon emission computed tomography (SPECT) market by End Use, 2018 - 2030 (USD Million)
  • Table 54 Japan single-photon emission computed tomography (SPECT) market by Product, 2018 - 2030 (USD Million)
  • Table 55 Japan single-photon emission computed tomography (SPECT) market by Application, 2018 - 2030 (USD Million)
  • Table 56 Japan single-photon emission computed tomography (SPECT) market by End Use, 2018 - 2030 (USD Million)
  • Table 57 India single-photon emission computed tomography (SPECT) market by Product, 2018 - 2030 (USD Million)
  • Table 58 India single-photon emission computed tomography (SPECT) market by Application, 2018 - 2030 (USD Million)
  • Table 59 India single-photon emission computed tomography (SPECT) market by End Use, 2018 - 2030 (USD Million)
  • Table 60 Australia single-photon emission computed tomography (SPECT) market by Product, 2018 - 2030 (USD Million)
  • Table 61 Australia single-photon emission computed tomography (SPECT) market by Application, 2018 - 2030 (USD Million)
  • Table 62 Australia single-photon emission computed tomography (SPECT) market by End Use, 2018 - 2030 (USD Million)
  • Table 63 Thailand single-photon emission computed tomography (SPECT) market by Product, 2018 - 2030 (USD Million)
  • Table 64 Thailand single-photon emission computed tomography (SPECT) market by Application, 2018 - 2030 (USD Million)
  • Table 65 Thailand single-photon emission computed tomography (SPECT) market by End Use, 2018 - 2030 (USD Million)
  • Table 66 South Korea single-photon emission computed tomography (SPECT) market by Product, 2018 - 2030 (USD Million)
  • Table 67 South Korea single-photon emission computed tomography (SPECT) market by Application, 2018 - 2030 (USD Million)
  • Table 68 South Korea single-photon emission computed tomography (SPECT) market by End Use, 2018 - 2030 (USD Million)
  • Table 69 Latin America single-photon emission computed tomography (SPECT) market by Product, 2018 - 2030 (USD Million)
  • Table 70 Latin America single-photon emission computed tomography (SPECT) market by Application, 2018 - 2030 (USD Million)
  • Table 71 Latin America single-photon emission computed tomography (SPECT) market by End Use, 2018 - 2030 (USD Million)
  • Table 72 Latin America single-photon emission computed tomography (SPECT) market by Country, 2018 - 2030 (USD Million)
  • Table 73 Brazil single-photon emission computed tomography (SPECT) market by Product, 2018 - 2030 (USD Million)
  • Table 74 Brazil single-photon emission computed tomography (SPECT) market by Application, 2018 - 2030 (USD Million)
  • Table 75 Brazil single-photon emission computed tomography (SPECT) market by End Use, 2018 - 2030 (USD Million)
  • Table 76 Argentina single-photon emission computed tomography (SPECT) market by Product, 2018 - 2030 (USD Million)
  • Table 77 Argentina single-photon emission computed tomography (SPECT) market by Application, 2018 - 2030 (USD Million)
  • Table 78 Argentina single-photon emission computed tomography (SPECT) market by End Use, 2018 - 2030 (USD Million)
  • Table 79 Middle East & Africa single-photon emission computed tomography (SPECT) market by Product, 2018 - 2030 (USD Million)
  • Table 80 Middle East & Africa single-photon emission computed tomography (SPECT) market by Application, 2018 - 2030 (USD Million)
  • Table 81 Middle East & Africa single-photon emission computed tomography (SPECT) market by End Use, 2018 - 2030 (USD Million)
  • Table 82 Middle East & Africa single-photon emission computed tomography (SPECT) market by Country, 2018 - 2030 (USD Million)
  • Table 83 South Africa single-photon emission computed tomography (SPECT) market by Product, 2018 - 2030 (USD Million)
  • Table 84 South Africa single-photon emission computed tomography (SPECT) market by Application, 2018 - 2030 (USD Million)
  • Table 85 South Africa single-photon emission computed tomography (SPECT) market by End Use, 2018 - 2030 (USD Million)
  • Table 86 Saudi Arabia single-photon emission computed tomography (SPECT) market by Product, 2018 - 2030 (USD Million)
  • Table 87 Saudi Arabia single-photon emission computed tomography (SPECT) market by Application, 2018 - 2030 (USD Million)
  • Table 88 Saudi Arabia single-photon emission computed tomography (SPECT) market by End Use, 2018 - 2030 (USD Million)
  • Table 89 UAE single-photon emission computed tomography (SPECT) market by Product, 2018 - 2030 (USD Million)
  • Table 90 UAE single-photon emission computed tomography (SPECT) market by Application, 2018 - 2030 (USD Million)
  • Table 91 UAE single-photon emission computed tomography (SPECT) market by End Use, 2018 - 2030 (USD Million)
  • Table 92 Kuwait single-photon emission computed tomography (SPECT) market by Product, 2018 - 2030 (USD Million)
  • Table 93 Kuwait single-photon emission computed tomography (SPECT) market by Application, 2018 - 2030 (USD Million)
  • Table 94 Kuwait single-photon emission computed tomography (SPECT) market by End Use, 2018 - 2030 (USD Million)

List of Figures

  • Fig. 1 Market research process
  • Fig. 2 Data triangulation techniques
  • Fig. 3 Primary research pattern
  • Fig. 4 Market research approaches
  • Fig. 5 Value-chain-based sizing & forecasting
  • Fig. 6 QFD modeling for market share assessment
  • Fig. 7 Market formulation & validation
  • Fig. 8 Market summary, 2023 (USD Million)
  • Fig. 9 Market segmentation & scope
  • Fig. 10 Market driver impact
  • Fig. 11 Market restraint impact
  • Fig. 12 Porter's analysis
  • Fig. 13 SWOT analysis
  • Fig. 14 Single-photon emission computed tomography (SPECT) market: Product outlook and key takeaways
  • Fig. 15 Single-photon emission computed tomography (SPECT) market: Product movement analysis
  • Fig. 16 Stand-alone SPECT Systems market, 2018 - 2030 (USD Million)
  • Fig. 17 Hybrid SPECT Systems market, 2018 - 2030 (USD Million)
  • Fig. 18 Single-photon emission computed tomography (SPECT) market: Application outlook and key takeaways
  • Fig. 19 Single-photon emission computed tomography (SPECT) market: Application movement analysis
  • Fig. 20 Cardiology market, 2018 - 2030 (USD Million)
  • Fig. 21 Oncology market, 2018 - 2030 (USD Million)
  • Fig. 22 Neurology market, 2018 - 2030 (USD Million)
  • Fig. 23 Other Application market, 2018 - 2030 (USD Million)
  • Fig. 24 Single-photon emission computed tomography (SPECT) market: End Use outlook and key takeaways
  • Fig. 25 Single-photon emission computed tomography (SPECT) market: End Use movement analysis
  • Fig. 26 Hospitals market, 2018 - 2030 (USD Million)
  • Fig. 27 Diagnostics imaging centers market, 2018 - 2030 (USD Million)
  • Fig. 28 Research & Development Institutes market, 2018 - 2030 (USD Million)
  • Fig. 29 Neurology imaging centers market, 2018 - 2030 (USD Million)
  • Fig. 30 Other end users market, 2018 - 2030 (USD Million)
  • Fig. 31 Single-photon emission computed tomography (SPECT) market: Regional movement analysis
  • Fig. 32 Single-photon emission computed tomography (SPECT) market: Regional outlook and key takeaways
  • Fig. 33 North America, by country
  • Fig. 34 North America
  • Fig. 35 North America market estimates and forecasts, 2018 - 2030
  • Fig. 36 U.S.
  • Fig. 37 U.S. market estimates and forecasts, 2018 - 2030
  • Fig. 38 Canada
  • Fig. 39 Canada market estimates and forecasts, 2018 - 2030
  • Fig. 40 Mexico
  • Fig. 41 Mexico market estimates and forecasts, 2018 - 2030
  • Fig. 42 Europe
  • Fig. 43 Europe market estimates and forecasts, 2018 - 2030
  • Fig. 44 UK
  • Fig. 45 UK market estimates and forecasts, 2018 - 2030
  • Fig. 46 Germany
  • Fig. 47 Germany market estimates and forecasts, 2018 - 2030
  • Fig. 48 France
  • Fig. 49 France market estimates and forecasts, 2018 - 2030
  • Fig. 50 Italy
  • Fig. 51 Italy market estimates and forecasts, 2018 - 2030
  • Fig. 52 Spain
  • Fig. 53 Spain market estimates and forecasts, 2018 - 2030
  • Fig. 54 Denmark
  • Fig. 55 Denmark market estimates and forecasts, 2018 - 2030
  • Fig. 56 Sweden
  • Fig. 57 Sweden market estimates and forecasts, 2018 - 2030
  • Fig. 58 Norway
  • Fig. 59 Norway market estimates and forecasts, 2018 - 2030
  • Fig. 60 Asia Pacific
  • Fig. 61 Asia Pacific market estimates and forecasts, 2018 - 2030
  • Fig. 62 China
  • Fig. 63 China market estimates and forecasts, 2018 - 2030
  • Fig. 64 Japan
  • Fig. 65 Japan market estimates and forecasts, 2018 - 2030
  • Fig. 66 India
  • Fig. 67 India market estimates and forecasts, 2018 - 2030
  • Fig. 68 Thailand
  • Fig. 69 Thailand market estimates and forecasts, 2018 - 2030
  • Fig. 70 South Korea
  • Fig. 71 South Korea market estimates and forecasts, 2018 - 2030
  • Fig. 72 Australia
  • Fig. 73 Australia market estimates and forecasts, 2018 - 2030
  • Fig. 74 Latin America
  • Fig. 75 Latin America market estimates and forecasts, 2018 - 2030
  • Fig. 76 Brazil
  • Fig. 77 Brazil market estimates and forecasts, 2018 - 2030
  • Fig. 78 Argentina
  • Fig. 79 Argentina market estimates and forecasts, 2018 - 2030
  • Fig. 80 Middle East and Africa
  • Fig. 81 Middle East and Africa market estimates and forecasts, 2018 - 2030
  • Fig. 82 South Africa
  • Fig. 83 South Africa market estimates and forecasts, 2018 - 2030
  • Fig. 84 Saudi Arabia
  • Fig. 85 Saudi Arabia market estimates and forecasts, 2018 - 2030
  • Fig. 86 UAE
  • Fig. 87 UAE market estimates and forecasts, 2018 - 2030
  • Fig. 88 Kuwait
  • Fig. 89 Kuwait market estimates and forecasts, 2018 - 2030
  • Fig. 90 Heat map analysis
  • Fig. 91 Market participant categorization
  • Fig. 92 Single-photon emission computed tomography (SPECT) market share analysis, 2022
  • Fig. 93 Strategy framework